Work

Sequencing in the post-immunotherapy era: Does second-line tyrosine kinase inhibitor choice impact survival and safety in advanced HCC?

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4140

Authors: Ansy Patel, Deevyashali Parekh, Devashish Desai, Vishw Patel, Vedant Shah, Kesar Prajapati, Shivam Chetankumar Patel, Rahul Seth

Institutions: SUNY Upstate Medical University, New York Medical College, St. Mary's Hospital, Metropolitan Hospital Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162555780

Cites:

Cited by:

Related to: